Stimulation of thymidine incorporation by basic fibroblast growth factor or epidermal growth factor treatment of cultured quiescent smooth muscle cells (rat and human) was attenuated by the concomitant treatment with interleukin-1, in the presence of indomethacin. Platelet-derived growth factor-AB and -BR-induced thymidine incorporation was not inhibited by the presence of the cytokine under similar experimental conditions. Elevation of nitrite levels in the conditioned medium of cultures exposed to interleukin-1ff correlated with the inhibition of thymidine incorporation. Platelet-derived growth factor-AB and -BB inhibited the production of nitric oxide (measured as nitrite levels in conditioned medium) by cells treated simultaneously with interleukin-l,B and growth factor. However, platelet-derived growth factor-AA neither affected nitrite production nor thymidine incorporation by smooth muscle cells. Levels of cytokine-stimulated nitrite production by smooth muscle cells were increased synergistically by the presence of fibroblast growth factors or epidermal growth factor. The inhibition of thymidine incorporation and concomitant elevation of nitrite production was abolished in the presence of nitro-L-arginine. Cultures maintained in the presence of low levels of the cytokine for 9 days were growth-inhibited, and this was reversed when culture medium was supplemented with nitro-L-arginine. The treatment of smooth muscle cells, which were grown in coculture inserts with the cytokine to induce nitric oxide production, before their combination with other quiescent layers of cells resulted in the inhibition of thymidine incorporation by this second layer of cells regardless of the growth factor used for stimulation. Nitric oxide may act as an endogenous inhibitor of smooth muscle cell proliferation in the vessel wall, and impairment of its production may be one action of potent vascular mitogens such as platelet-derived growth factor. (Circulation Research 1992;71:1088- 
Platelet-Derived Growth Factor Suppresses and
Fibroblast Growth Factor Enhances Cytokine-Induced Production Stimulation of thymidine incorporation by basic fibroblast growth factor or epidermal growth factor treatment of cultured quiescent smooth muscle cells (rat and human) was attenuated by the concomitant treatment with interleukin-1, in the presence of indomethacin. Platelet-derived growth factor-AB and -BR-induced thymidine incorporation was not inhibited by the presence of the cytokine under similar experimental conditions. Elevation of nitrite levels in the conditioned medium of cultures exposed to interleukin-1ff correlated with the inhibition of thymidine incorporation. Platelet-derived growth factor-AB and -BB inhibited the production of nitric oxide (measured as nitrite levels in conditioned medium) by cells treated simultaneously with interleukin-l,B and growth factor. However, platelet-derived growth factor-AA neither affected nitrite production nor thymidine incorporation by smooth muscle cells. Levels of cytokine-stimulated nitrite production by smooth muscle cells were increased synergistically by the presence of fibroblast growth factors or epidermal growth factor. The inhibition of thymidine incorporation and concomitant elevation of nitrite production was abolished in the presence of nitro-L-arginine. Cultures maintained in the presence of low levels of the cytokine for 9 days were growth-inhibited, and this was reversed when culture medium was supplemented with nitro-L-arginine. The treatment of smooth muscle cells, which were grown in coculture inserts with the cytokine to induce nitric oxide production, before their combination with other quiescent layers of cells resulted in the inhibition of thymidine incorporation by this second layer of cells regardless of the growth factor used for stimulation. Nitric oxide may act as an endogenous inhibitor of smooth muscle cell proliferation in the vessel wall, and impairment of its production may be one action of potent vascular mitogens such as platelet-derived growth factor. (Figure 10 ). Cell number determinations were performed 24 hours after the plating of cells (after the two medium changes described above) and every 48 hours thereafter on sets of quadruplicate wells exposed to the individual treatment regimes. Medium, with the appropriate additions, was replenished every second day (starting 48 hours after plating), and conditioned medium (exposed to cells for 24 hours) was collected from the wells used for cell number determinations. Aliquots of conditioned medium were assayed for nitrite content (see below).
Assay of nitrite levels in conditioned medium. The determination of the enzymatic production of NO from L-arginine by cultured cells was performed by measurement of the nitrite anion content of conditioned medium.9,24 Nitrite concentrations are determined using Greiss reagent (a 1:1 mixture of 1% sulfanilamide and 0.1% naphthylethylenediamine in 2% phosphoric acid) by a previously described method.25 Aliquots (400 ,ul) of conditioned medium were mixed with an equal volume of reagent, and after color development, optical density was determined at 540 nm. The concentration of unknowns was determined by comparison with values obtained from a standard curve using sodium nitrite. In preliminary kinetic experiments, it was found that incubation of cells (1-2x106) with IL-1p3 (1 ng/ml) for 20-24 hours resulted in levels of nitrite in cultured medium that could be monitored with good reproducibility. Since 27 Assay of intracellular and extracellular cGMP levels. The intracellular levels of cGMP and those in conditioned medium were determined by using a commercial radioimmunoassay kit (Biomedical Technologies Inc., Stoughton, Mass.) as previously described.28 After incubations of cells under the requisite experimental conditions, conditioned media were collected, and aliquots (100 g.l) were freeze-dried. Cell layers were washed (2x2 ml) with phosphate-buffered saline and extracted twice with 500 ,ul acidified (10 mM HCl) ethanol, and combined extracts were dried under vacuum. Dried cell and media extracts were then processed for radioimmunoassay determination of cGMP levels as previously described.28
Statistical Analysis
Results are expressed as mean-+-SD; on some occasions the SDs are not apparent when they are smaller than the symbols used in the figures. The number of experiments is denoted by n. Statistical comparisons were made by analysis of variance, and significant differences between treatments were determined by Scheffe's test (see Reference 29 for review). Values were considered statistically significant at p<0.05.
Results

Kinetics of [3H]Thymidine Incorporation into DNA and Nitrite Production
When quiescent cultures of rat smooth muscle cells were treated with either PDGF-AB or bFGF (in the presence of 10 ,M indomethacin), there was a timedependent enhancement in the incorporation of radioactive thymidine into DNA that reached maximal levels 28 hours after the start of treatments ( Figure 1A ). In the presence of IL-1,8, the levels of [3Hjthymidine incorporated into DNA in response to bFGF were depressed significantly, whereas PDGF-AB-stimulated incorporation was marginally increased ( Figure 1A) . (Table 1) . Therefore, nitrite anion concentrations in conditioned media were used as an index of NO production for the experiments reported here, and as indicated by the data (Table 1) , NO2 levels were greater than 75% of the total NO (N02+NO3) produced by cells in response to cytokine, in the presence and absence of growth factors. Thereafter, cell layers were processed for radioactive incorporation into DNA (see "Methods"), and the levels were determined as shown in panel A. Growth factors were used at 10 nglml in presence of 10 ,uMindomethacin, and similar experiments (n=2) were also performed twice on human smooth muscle cells.
Therefore, the levels of nitrate anions in conditioned media were not routinely determined.
cGMP Levels in Response to NO Production The elevation of intracellular cGMP levels in smooth muscle cells after treatment with cytokines has been reported by ourselves'5,16 and others,14 and this was confirmed under the conditions used for these studies (Table 1 ). All treatments of cells resulted in a significant increase in the intracellular levels of cGMP as compared with control unstimulated cells, and the levels paralleled those of both extracellular nitrite and cGMP levels ( Table 1 ). The elevations of extracellular levels of cGMP by the three growth factors tested were all significantly greater in the presence of IL-1f3 (Table 1) .
Effects of IL-1,8 on Growth Factor-Stimulated [3HiThymidine Incorporation
When quiescent cultures of aortic smooth muscle cells were exposed to a number of peptide growth factors in the presence of indomethacin, there was a threefold to eightfold stimulation in the incorporation of ['H]thymidine into DNA, which was dependent on the agonist used (Figures 2A and 3A) . PDGF-AB and (Figure 2A ). However, in the case of acidic fibroblast growth factor (aFGF), bFGF, and epidermal growth factor (EGF), there was a marked significant inhibition (+50%) in the levels of [3H]thymidine incorporated into DNA ( Figure 3A ). In the presence of nitro-L-arginine, this was no longer apparent ( Figure  3A) . Under similar conditions (in the presence of nitro-L-arginine), the effects of the three forms of Incubations were performed in serum-free culture medium (MEMTHA-SF) containing 10 uM indomethacin (Arg and Arg+IL 1), and some cultures were additionally exposed to the same medium containing 200 ,uM NLA (NLA and NLA +IL 1). Growth factors were used at 10 ng/ml, and initial incubations were for 28 hours, at which time aliquots were collected for nitrite anion determination (panel B). Thereafter, medium was replaced for a further 6 hours with MEMTH containing 10% fetal calf serum and 1.0 ,Ci/ml 3H-Tdr. At were obtained when cultures of human smooth muscle cells were used in experiments analogous to those described above ( Figure 4A ).
IL-1,/3-Stimulated Nitrite Production in the Presence and Absence of Growth Factors
When the levels of nitrite present in conditioned medium (MEMTHA-SF) were determined as an indicator of NO production (Table 1) , it was evident that IL-1,8 treatment of smooth muscle cells resulted in the production of nitrite and that this was attenuated significantly in the presence of PDGF-AB or -BB but not in the presence of PDGF-AA ( Figure 2B ). However, nitrite production was enhanced significantly in the presence of aFGF, bFGF, and EGF ( Figure 3B ). The production of nitrite was inhibited to a significant extent when cells were stimulated in serum-free medium containing low arginine (MEMTHA-SF) and nitro-L-arginine, a competitive inhibitor of NO synthase, regardless of the combinations of cytokine and growth factors to which cells were exposed (Figures 2 and 3B ). Similar findings were obtained when experiments were performed with human smooth muscle cell cultures ( Figure 4B ). No stimulation of nitrite production was observed with cultures of 3T3 fibroblasts treated under the same conditions described for smooth muscle cells (data not shown). Differential Stimulation of DNA Synthesis and Nitrite Production by PDGF-AB and bFGF in the Presence and Absence of IL -1 f
In an attempt to elucidate the differential effects of the two smooth muscle competence factors, PDGF-AB and bFGF, on DNA synthesis and the production of nitrite elicited by IL-1,B, rat smooth muscle cells were treated with increasing levels of IL-1,B in the presence and absence of either one of the two growth factors ( Figure 5 ). Interleukin-1l3 inhibited bFGF-elicited [3H]thymidine incorporation into DNA in a concentration-dependent manner, and this was mirrored by its action on PDGF-AB-dependent DNA synthesis ( Figure 5A ). The production of nitrite by smooth muscle cells in response to IL-1lB was concentration dependent, and this was enhanced significantly by the presence of bFGF ( Figure 5B ). The presence of PDGF-AB inhibited the production of nitrite by IL-1,B-treated cells at all levels of the cytokine tested ( Figure 5B). Similar results were obtained when aFGF or EGF was used in place of bFGF (data not shown).
The concentration-dependent stimulation of DNA synthesis by bFGF was inhibited completely by the presence of IL-1p, but the converse was observed for the incorporation of [3H]thymidine into DNA by smooth muscle cells in response to PDGF-AB ( Figure 6A ). The production of nitrite by smooth muscle cells in response to IL-1p was significantly enhanced at submitogenic levels (1 ng/ml) of bFGF and was concentration dependent ( Figure 6B ), whereas the presence of PDGF-AB at low concentrations abolished the cytokine-stimulated production of nitrite ( Figure 6B ). When added alone, neither growth factor stimulated the production of nitrite by cultures even at the maximal levels used in these experiments ( Figure 6B ). Similar results, with respect to the effects of bFGF and rat smooth muscle cells, were obtained using aFGF or EGF (data not shown). When experiments analogous to those described in Figures 5 and 6 were performed using the human smooth muscle cells, the findings with rat cells were confirmed (data not shown). However, higher levels (4.0 ng/ml) of IL-1l8 were required to maximally stimulate nitrite production in human cells when exposed to the cytokine alone. [Interleukin] ng/mI. Figure 7 ).
In contrast, the low levels of nitrite produced by cells in the presence of IL-183 and PDGF-AB increased significantly in parallel with the lateness of addition of the growth factor ( Figure 7 ). Similar effects were observed with PDGF-BB and EGF when these agonists were added at 2, 4, and 8 hours after the start of cytokine stimulation of rat smooth muscle cells (data not shown).
Thymidine Incorporation and Nitrite Production by Cells in Coculture Endogenously produced NO inhibited the stimulated incorporation of [3H]thymidine evoked by aFGF, bFGF, and EGF but appeared to have no inhibitory effect on the action of PDGF-AB (Figures 2, 3, and 4A) . The apparent explanation for the latter observation was that PDGF prevented the induction of NO production (measured as nitrite), and this was supported by the data shown in Figure 7 . However, it was not clear if NO was able to inhibit PDGF-stimulated [3H]thymidine incorporation per se. To investigate this aspect, rat smooth muscle cells, propagated in coculture inserts, were stimulated with IL-1p3 under the conditions indicated ( Figure 8 and "Methods") to induce long-term production of NO.15,16 These NO-producing cells were then combined with a quiescent monolayer of the same cell type to establish a coculture system. Once the coculture system was established, cells were stimulated with the growth factors (PDGF-AB, bFGF, or EGF) as indicated ( Figure 8 ). Under these conditions, in which nitrite production by IL-1,(-treated cells remained elevated, the incorporation of [3H]thymidine into DNA in response to PDGF-AB was reduced significantly (+50%, Figure 8 ). Similar findings were observed in the case of the other growth factors tested here (Figure 8 ). Inhibition of Long-term Proliferation by IL-1 Inhibition of smooth muscle cell incorporation of [3H]thymidine into DNA in response to aFGF, bFGF, or EGF showed a strong correlation (r2=0.89) with the levels of IL-1p-induced nitrite in the culture medium ( Figure 9 ). However, this does not imply that NO can inhibit smooth muscle cell growth, as measured by increases in cell number. Therefore, smooth muscle cells (rat or human) were grown in MEMTHA-SF supplemented with 0.1% plasma-derived serum and bFGF to promote a slow sustained rate of growth ( Figure 10 ). Addition of low levels of IL-1,B resulted in a significant inhibition of proliferation ( Figure 10 ). When culture medium was supplemented further with nitro-L-arginine, the depression of growth observed in the presence of cytokine was no longer apparent (rat smooth muscle cells) or significantly reduced (human smooth muscle cells, Figure 10 ). The levels of nitrite accumulated into conditioned medium for each 24-hour growth period between medium changes and the determination of cell number (see "Methods") were measured and found to correlate closely with growth inhibition ( Figure 11 ). In the absence of bFGF, cell numbers after 9 days in culture were 1.80+0.21x 105/ cm2 for rat cells and 1.64±0.19x 10'/cm2 for human cells. At the end of experiments (day 9), aliquots of trypsinized cells were replated into culture dishes, and cell numbers were determined after 24 hours to estimate plating efficiency. This (Table 1) . Thus, the level of nitrite in conditioned media serves as a good index of the production of NO by smooth muscle cells exposed to cytokines.914-16 Additionally, there was a large increase in the levels of cGMP that accumulated in conditioned media, as reported previously for studies with agonists that elevate intracellular levels of cyclic nucleotide. 28, 31 This increase was parallel to the increases in nitrite anion levels ( Table 1 ). The concomitant increases in intracellular cGMP observed in these studies (Table 1) are consistent with the intracellular action of NO and have been reported by a number of laboratories including our own.11, [13] [14] [15] [16] The levels of inorganic nitrite correlated strongly with the degree of inhibition of [3H]thymidine incorporation into DNA by cells in response to aFGF, bFGF, or EGF ( Figure 9 ). Inhibition of DNA synthesis by cytokineinduced nitrite (NO) production was attenuated by the inclusion of nitro-L-arginine in the culture media used for these experiments (MEMTHA). Although the mitogenic effects of aFGF, bFGF, and EGF were small as compared with PDGF, they are consistent with previous findings. FIGURE 11 . Bar graphs showing nitrite levels in conditioned medium from growth kinetic experiments. Arg, L-arginine; IL 1, interleukin-1 (3; NLA, nitro-L-arginine. Cells were cultured as described for Figure 10 and in 'Methods, " and the levels of nitrite present in conditioned medium were determined for each 24-hourperiod preceding the determination of cell numbers ( Figure 10 ). Cells were grown in MEMTI-4 containing 0.1% plasma-derived serum, 10 ng/ml basic fibroblast growth factor, and 10 ,uM indomethacin (Arg) in the presence ( nism(s) that are not wholly dependent on the levels of PDGF a-subunit receptor expression but are facilitated by the concomitant expression of other growth factors such as bFGF. 35 The actions of PDGF-BB and -AB on the production of nitrite by IL-1f3-stimulated cells mimicked that of nitro-L-arginine. However, whereas the mechanism of action of the arginine analogue has been extensively studied,9 little is known about this aspect of the growth factors' actions. The data presented here demonstrate that under in vitro conditions PDGF does not negate the de facto action of NO, since in the coculture studies, once NO was in full production, inhibition of PDGFstimulated DNA synthesis was clearly apparent. Also, for PDGF to exert a full inhibitory effect on the induction of NO synthase by IL-113, the presence of the growth factor was required at the start of the cytokine induction period (Figure 7 ). This strongly suggests that PDGF is acting by the production of factors that interfere with gene expression induced by IL-13. Recent work suggests that IL-1,8-induced inhibition of tumor growth is dependent on the activation of "early" gene expression programs; interference with this action of the cytokine eliminates its ability to inhibit tumor cell growth. 36 The mechanism(s) of action of bFGF on the promo- Both forms of FGF (acidic and basic) have a hypotensive effect when infused into anesthetized rats and rabbits, and this can be prevented by nitro-L-arginine. 40 Thus, there is some evidence in vivo that members of the heparin-binding growth factor family either interact with or promote the action of EDRF. The source of NO (EDRF) was assumed to be the endothelium in the studies using fibroblast growth factor infusions.40 However, it is possible that the relaxation observed was due to NO produced by the smooth muscle cells themselves as a consequence of the synergistic action of fibroblast growth factor (acidic or basic) and cytokine. The production of interleukin-1 by smooth muscle cells has been demonstrated,41 and the data presented here indicate that, in the presence of FGF, minimal levels of cytokine induce a robust production of NO, measured as nitrite (Figures 5 and 6) .
One established metabolic consequence of the IL- The coculture studies reported here emphasized the fact that, once the NO synthase has been induced in cultured smooth muscle cells, production of NO continues in the absence of further stimulation with cytokine. When nitrite levels were measured after a 24-hour cytokine stimulation period and then again 24 hours later after two washes with serum-free medium, there was no significant difference in the amount of the anion produced ( Figure 8 ). This illustrated that, once induced, enzyme activity remains elevated for some time and that this results in the prolonged production of NO. The lability of the NO is apparently offset by its robust production by cytokine-stimulated rat smooth muscle cells.45 NO production (measured as nitrite) by human smooth muscle cells was less robust than that of rat cells and decayed more rapidly. Furthermore, growth inhibition of human smooth muscle cells in coculture was significant only if IL-1,B-treated rat smooth muscle cells were used as the donors of NO (data not shown). Inclusion of cycloheximide in culture medium during IL-1,B stimulation of smooth muscle cells prevented the induction of NO synthase activity (nitrite production), which is suggestive of de novo synthesis of the enzyme. 16 Inhibition of thymidine incorporation may be taken as a good indicator of growth inhibition. Additionally, the fact that IL-1,8 inhibited the increase in cell number of smooth muscle cells grown in an essentially defined culture medium illustrated that NO could act as a locally produced endogenous smooth muscle growth inhibitor. It is important that the inhibition demonstrated here in the long-term growth studies appeared to be unrelated to a cytotoxic action of NO, since on replating of cells there was no significant difference in viability (as assessed by plating efficiency) between those cells exposed to NO for the duration of the experiment and those that were not so exposed.
The endogenous production of NO in the vessel wall has important consequences for not only the maintenance of vascular tone but also as already mentioned for the depression of smooth muscle proliferation. Much of the data that has been accumulated so far on growth regulation of vascular smooth muscle has emphasized the induction of growth stimulatory compounds, namely the promotion of growth. Growth stimulation may also occur if there is an impairment of mechanisms that normally inhibit proliferation. If under normal circumstances the endogenous production of NO (by smooth muscle and/or endothelial cells) plays a role in the depression of growth, the action of potent mitogens like PDGF may be twofold, involving both the stimulation of growth directly and the inhibition of NO synthase this presumably results also in activation of cGMPinduction. However, it remains to be demonstrated in vivo whether NO synthase induction (by cytokines for example) can be repressed by growth factors like PDGF. Once the synthase is induced, PDGF appears unable to modulate its activity (Figure 8 ). These data suggest that EDRF, namely NO, may function as a regulator of vascular growth as well as smooth muscle tone in the blood vessel wall. Furthermore, cytokineinduced NO production by smooth muscle may be important in the restoration of smooth muscle growth quiescence after injury to the endothelium. 45 
